SEC Form D · filed June 15, 2015
Syndax Pharmaceuticals Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (22)
Ivor Royston · Waltham, MADirectorMichael W. Metzger · Waltham, MAExecRichard P. Shea · Waltham, MADirectorGeorge W. Sledge, Jr. M.D · Waltham, MADirectorFabrice Egros, Ph.D · Waltham, MADirectorJohn Pallies · Waltham, MAExecLuke Evnin, Ph.D · Waltham, MADirectorKim Kamdar, Ph.D · Waltham, MADirectorDennis Podlesak · Waltham, MADirectorHenry W. Chen · Waltham, MADirectorAlex Gleser · FORT WORTH, TXDirectorRichard J. Berman · Boston, MAExecRichard C. Temme · Woodland Hills, CADirectorLeslie P. Temme · Woodland Hills, CADirectorRonald P. Kirkpatrick · Ponte Verde, FLExecRichard G. Chyette · Livonia, MIDirectorRamkumar Mandalam · San Carlos, CADirectorLowell G. Sears · San Carlos, CADirectorGisela G. Schwab · San Carlos, CADirectorAlbert Rabil, Iii · Boca Raton, FLDirectorH. Philip A. Goodeve · Boston, MADirectorDaniel H. Schneiderman · Boston, MAExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗